secwatch.observer — SEC 8-K summary
======================================

Issuer:     Odysight.ai Inc. (ODYS)
CIK:        0001577445
Form:       8-K
Filed at:   2023-10-17T23:59:59+00:00
Accession:  0001493152-23-037452
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Odysight.ai receives $3.3M purchase order from Fortune 500 medical partner for FY2024
--------------------------------------------------------------------------------

- Expanded PO from Fortune 500 orthopaedic company totals $3.3M for fiscal year 2024.
- Visual technology integrated into partner's FDA-approved minimally invasive surgical device.
- Builds on prior January 2023 announcement; company expects substantial future growth.
- CEO Yehu Ofer: trusted by Fortune 500 in critical medical technology field.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1577445/000149315223037452/0001493152-23-037452-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1577445/000149315223037452/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-037452

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer